Carolyn Lentzsch Parcells, MD

Extended-release stimulants have become first-line therapy for adult ADHD, replacing outdated practices that once set patients up for failed medication trials. The panel explains why.

ADHD rarely confines itself to one area of an adult's life. The panel traces how the condition's burden compounds across work, family, and relationships as responsibilities grow.

Untreated ADHD carries measurable costs in relationships, careers, and even life expectancy. The panel makes the clinical case for diagnosing and treating adult ADHD as early as possible.

Many adults with ADHD are hiding in plain sight behind a prior anxiety or depression diagnosis. The panel examines underdiagnosis trends and how to identify ADHD beneath common comorbid conditions.

Diagnosing adult ADHD demands more than a single office visit. The panel outlines the history-taking, collateral information, and follow-up structure needed to reach a confident, accurate diagnosis.

Adult ADHD is more common than clinicians assume, and its symptoms look different from the classic childhood presentation. The panel opens by reframing prevalence and heterogeneity as the foundation for accurate diagnosis.